Validea Detailed Fundamental Analysis

Validea's guru fundamental report indicates that Johnson & Johnson (JNJ) receives a rating of 87% based on their Multi-Factor Investor model, inspired by Pim van Vliet's strategy of seeking low volatility stocks with strong momentum and high net payout yields; while JNJ passes tests for market cap and standard deviation, it is neutral on momentum and net payout yield, and ultimately fails the final rank within this specific model.

Analysis

Johnson & Johnson (JNJ) has been evaluated by Validea's guru fundamental report, specifically using the Multi-Factor Investor model based on Pim van Vliet's strategy, which targets low volatility stocks exhibiting strong momentum and high net payout yields. JNJ achieved a rating of 87% under this model, a score that typically signifies some level of interest. The company successfully passed criteria related to its market capitalization and standard deviation, indicating favorable low volatility characteristics. However, JNJ received a "NEUTRAL" assessment for both "TWELVE MINUS ONE MOMENTUM" and "NET PAYOUT YIELD". Despite the 87% score, the stock ultimately registered a "FAIL" on the "FINAL RANK" within this particular strategy's framework. The general sentiment for JNJ is moderately positive (0.6), highlighting a nuanced situation where the stock shows promise in some aspects of the model but falls short on others critical to this specific investment philosophy.

Key Decisions for Investors

• Investors strictly following Pim van Vliet's multi-factor strategy should note JNJ's 'FAIL' on the final rank and 'NEUTRAL' assessments for momentum and net payout yield, despite its positive low volatility attributes.
• The 87% initial rating and moderately positive specific sentiment for JNJ are encouraging, but these must be weighed against its inability to meet all key criteria of this particular conservative, factor-based model, particularly regarding momentum and yield.
• Further due diligence is warranted to understand the drivers behind JNJ's neutral momentum and payout yield, and its overall investment merit should be assessed using a broader range of analytical tools beyond this single strategy's specific outcome.